|
There are more than 100 types of cancer. While some cancers are
common, others such as sarcomas are very rare.
Sarcomas occur in bone and soft tissue, accounting for approximately
one percent of adult cancers and 15 percent of childhood cancers.
Limited understanding and misdiagnosis led to poor prognoses for
sarcoma patients in the past. Sarcoma Services at Huntsman Cancer
Institute (HCI) aims to reduce the incidence and improve outcomes
of sarcomas through collaborative research and comprehensive treatment.
Directed by R. Lor Randall, MD, FACS, HCI investigator and associate
professor in the Department of Orthopaedics at the University of
Utah, the Sarcoma Services team includes a multidisciplinary group
of experts, from oncologists and radiologists to scientists and
social workers. The team treats patients of all ages across the
Intermountain West.
“Sarcoma Services is a paragon of the ‘sum is greater
than its parts’ metaphor,” says Randall. “Our
multidisciplinary approach has dramatically improved the clinical
care available to sarcoma patients. Just as important are the contributions
made by our basic and translational researchers as they search for
novel treatments with fewer side effects.”
Sarcoma Services researchers investigate the causes of this disease
in a variety of settings, including HCI’s Sarcoma Array Research
Consortium (SARC) Lab, and the labs of HCI investigators Lessnick,
Virshup, Beckerle, and Bernard. Studies include molecular analyses
of aggressive sarcomas. “This helps us identify how cancer
cells work in sarcomas and why,” explains Randall.
HCI’s Sarcoma Services also collaborates with leaders at
the national and
international levels. These include the National Cancer Institute,
the National Comprehensive Cancer Network, Children’s Oncology
Group, the Southwest Oncology Group, and others. “By sharing
data and results, scientists and physicians learn from and build
upon each other’s work,” says Randall, “which
results in better, more rapid
outcomes for patients.”
|